Renasciencepharma
About Renasciencepharma
Renasciencepharma is a Healthcare company, and was acquired by Lupin in April 2025. Critical care pharmaceuticals are manufactured to revive forgotten medicines. Its focus areas include Traditional Pharmaceuticals. Its legal entity is Renascience Pharma Ltd.
Company details
Operations in the pharmaceutical sector are conducted by Renasciencepharma, with a focus on critical care medications. Unmet clinical needs are addressed through the revival of essential, previously discontinued drugs. A portfolio including antibiotics and ear drop solutions is developed and manufactured under strict quality controls. Ethical practices are integrated across all production stages, ensuring compliance with industry standards. Patient requirements are prioritized in product formulation and distribution processes.
- Stage Acquired
- SectorsHealthcare
- Website renasciencepharma.com
- Acquired by Lupin (Apr 2025)
- Legal Name Renascience Pharma Ltd
Investors in Renasciencepharma
Renasciencepharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lupin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical products including generics, biosimilars, and APIs are manufactured. | 1968 | lupin.com | Mumbai, India |
Investor details for Renasciencepharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Renasciencepharma
Operations in the pharmaceutical sector are conducted by Renasciencepharma, with a focus on critical care medications. Unmet clinical needs are addressed through the revival of essential, previously discontinued drugs. A portfolio including antibiotics and ear drop solutions is developed and manufactured under strict quality controls. Ethical practices are integrated across all production stages, ensuring compliance with industry standards. Patient requirements are prioritized in product formulation and distribution processes.
Renasciencepharma has 1 investor. Key investors include Lupin.
Renasciencepharma operates through Renascience Pharma Ltd.
Yes. Renasciencepharma was acquired by Lupin in April 2025.